Name: UMIN ID:
Unique ID issued by UMIN | UMIN000017069 |
---|---|
Receipt number | R000019773 |
Scientific Title | Randomized phase III study comparing erlotinib plus bevacizumab to erlotinib alone in patients with previously untreated non-small cell lung cancer harboring EGFR mutation (NEJ026) |
Date of disclosure of the study information | 2015/04/07 |
Last modified on | 2018/08/09 21:04:36 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/04/07 22:58:20 | ||
2 | Update | 2015/04/07 23:09:27 | Acronym Acronym |
|
3 | Update | 2015/05/20 12:05:13 | Recruitment status |
|
4 | Update | 2016/09/05 11:09:33 | Recruitment status |
|
5 | Update | 2018/04/09 16:25:39 | Results Other related information |
|
6 | Update | 2018/08/09 21:01:07 | Organization Organization Division name Division name Address Address TEL Name of primary person or sponsor Organization |
|
7 | Update | 2018/08/09 21:03:03 | Publication of results Other related information |
|
8 | Update | 2018/08/09 21:04:36 | Key inclusion criteria Key inclusion criteria |